Kurs Repros Therapeutics Inc

Aktien

26.01.18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15.12.17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12.12.17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12.12.17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12.12.17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	Perf. 1 Jahr	Perf. 3 Jahre	Marktkap.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
WUXI APPTEC CO., LTD.	-3.10%	-4.19%	+32.67%	+59.47%	65.28 Mrd.
ARGENX SE	+0.33%	+0.33%	+10.16%	+78.07%	54.57 Mrd.
LONZA GROUP AG	+0.16%	+1.73%	+9.89%	+102.10%	53.59 Mrd.
IQVIA HOLDINGS INC.	-0.75%	+1.38%	+24.89%	+50.91%	45.03 Mrd.
BEONE MEDICINES AG	-1.30%	-4.80%	+16.05%	+114.76%	42.17 Mrd.
REVOLUTION MEDICINES, INC.	+1.26%	-5.26%	+221.12%	+900.64%	39.42 Mrd.
CELLTRION, INC.	-0.74%	-4.46%	+11.00%	+44.65%	32.71 Mrd.
WUXI BIOLOGICS (CAYMAN) INC.	-2.70%	-10.77%	+19.80%	-6.47%	24.01 Mrd.
GENMAB A/S	+1.11%	+15.18%	+60.27%	+49.33%	26.5 Mrd.
Durchschnitt	-0.57%	+1.98%	+45.09%	+154.83%	42.59 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt	-0.72%	+1.72%	+42.17%	+153.57%